Scheuermann, Jörg, PD Dr.
Principal Investigator
Group head "DNA-encoded chemical libraries / DEL technology"
and Privatdozent at ETH Zurich

Jörg Scheuermann studied Chemistry at the University of Heidelberg (Germany) and at the ETH Zurich (Switzerland). During his Ph.D. studies at the ETH Zurich he worked on the identification of novel binding molecules to markers of angiogenesis. Since 2002, together with Dario Neri, he developed DNA-encoded library technology in different implementations. He has published 62 peer-reviewed articles on DEL technology and wrote his habilitation on "DNA-Encoded Chemical Library Technology for Drug Discovery". He is organizer of the "International Symposium on DNA-Encoded Chemical Libraries", a yearly alternating event between ETH Zurich/Switzerland, Boston/US and China. He is Principal Investigator at ETH Zurich, heading a group of five PhD students and one Postdoc. His research interests are the further development of DEL

Universal encoding of next generation DNA-encoded chemical libraries
Chem. Sci., 2022, doi: 10.1039/D1SC05721A
DNA-encoded chemical libraries (DELs) are useful tools for the discovery of small molecule ligands to protein targets of pharmaceutical interest. Compared with single-pharmacophore DELs, dual-pharmacophore DELs simultaneously display two chemical moieties on both DNA strands, and allow for the construction of highly diverse and pure libraries, with a potential for targeting larger protein surfaces. Although methods for the encoding of simple, fragment-like dual-display libraries have been established, more complex libraries require a different encoding strategy. Here, we present a robust and convenient "large encoding design" (LED), which facilitates the PCR-amplification of multiple codes distributed among two partially complementary DNA strands. We experimentally implemented multiple coding regions and we compared the new DNA encoding scheme with previously reported dual-display DEL modalities in terms of amplifiability and performance in test selections against two target proteins. With the LED methodology in place, we foresee the construction and screening of DELs of unprecedented sizes and designs.
309 642 258 397
Specific Inhibitor of Placental Alkaline Phosphatase Isolated from a DNA-Encoded Chemical Library Targets Tumor of the Female Reproductive Tract
J. Med. Chem. 2021, 64, 21, 15799–15809
Placental alkaline phosphatase (PLAP) is an abundant surface antigen in the malignancies of the female reproductive tract. Nevertheless, the discovery of PLAP-specific small organic ligands for targeting applications has been hindered by ligand cross-reactivity with the ubiquitous tissue non-specific alkaline phosphatase (TNAP). In this study, we used DNA-encoded chemical libraries to discover a potent (IC50 = 32 nM) and selective PLAP inhibitor, with no detectable inhibition of TNAP activity. Subsequently, the PLAP ligand was conjugated to fluorescein; it specifically bound to PLAP-positive tumors in vitro and targeted cervical cancer in vivo in a mouse model of the disease. Ultimately, the fluorescent derivative of the PLAP inhibitor functioned as a bispecific engager redirecting the killing of chimeric antigen receptor-T cells specific to fluorescein on PLAP-positive tumor cells.
231 378 438 219
Affinity selections of DNA‐encoded chemical libraries on carbonic anhydrase IX‐expressing tumor cells reveal a dependence on ligand valence
Chem. Eur. J., 2021, 27(35), 8985-8993
DNA‐encoded chemical libraries are typically screened against purified protein targets. Recently, cell‐based selections with encoded chemical libraries have been described, commonly revealing suboptimal performance due to insufficient recovery of binding molecules. We used carbonic anhydrase IX (CAIX)‐expressing tumor cells as a model system to optimize selection procedures with code‐specific quantitative polymerase chain reaction (qPCR) as selection readout. Salt concentration and performing PCR on cell suspension had the biggest impact on selection performance, leading to 15‐fold enrichment factors for high‐affinity monovalent CAIX binders (acetazolamide; K D = 8.7 nM). Surprisingly, the homobivalent display of acetazolamide at the extremities of both complementary DNA strands led to a substantial improvement of both ligand recovery and enrichment factors (above 100‐fold). The optimized procedures were used for selections with a DNA‐encoded chemical library comprising 1 million members against tumor cell lines expressing CAIX, leading to a preferential recovery of known and new ligands against this validated tumor‐associated target. This work may facilitate future affinity selections on cells against target proteins which might be difficult to express otherwise.
537 642 212 356
Ready to start your project at HitS?
DNA-Compatible Copper-Catalyzed
2021.8.15 likes 87
We report a DNA-compatible protocol for synthesizing amides from DNA-bound aldehydes and non-nucleophilic arylamines including aza-substituted anilines, 2-aminobenzimidazoles, and 3-aminopyrazoles.The reactions were carried out at room temperature and provided reasonable conversions and wide functional group compatibility.
Comment
Karl:
Very good idea, the author is a person who dares to practice and hopes to continue to work hard.
2021.08.15
Karl:
Very good idea, the author is a person who dares to practice and hopes to continue to work hard.
2021.08.15
Karl:
Very good idea, the author is a person who dares to practice and hopes to continue to work hard.
2021.08.15
WuXi AppTec HitS unit provides one-stop Target-to-Hit services that enable companies in the pharmaceuticals, biotech, and academics worldwide to seek premium drug discovery.
Contact Us
HitS_service@wuxiapptec.com
DEL_service@wuxiapptec.com
US: +1 (857) 500-0235
China: +86 (021) 2066-3521
Online inquiry
  • WuXi AppTec China
    240 Hedan Road, Shanghai 200131, China
    1318 Wuzhong Avenue, Suzhou 215104, China
  • WuXi AppTec US
    Suite 111, 22 Strathmore Road Natick
    MA 01760-2434, USA
  • Crelux GmbH, a WuXi AppTec Company
    Am Klopferspitz 19a
    82152 Martinsried, Germany
Copyright © 2020 WuXi AppTec, All Rights Reserved.